mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.01 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |